We are live on ! Find out more
ARNA

Arena Pharmaceuticals Inc

Delisted

ARNA was delisted on the 10th of March, 2022.

129 hedge funds and large institutions have $628M invested in Arena Pharmaceuticals Inc in 2014 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 33 increasing their positions, 44 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% less capital invested

Capital invested by funds: $645M → $628M (-$16.9M)

10% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 21

2% less funds holding

Funds holding: 131129 (-2)

25% less repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 44

47% less call options, than puts

Call options by funds: $22.8M | Put options by funds: $43.1M

Holders
129
Holders Change
-2
Holders Change %
-1.53%
% of All Funds
3.71%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
19
Increased
33
Reduced
44
Closed
21
Calls
$22.8M
Puts
$43.1M
Net Calls
-$20.2M
Net Calls Change
+$4.67M
Name Holding Trade Value Shares
Change
Change in
Stake
PAMU
26
Pictet Asset Management (UK)
United Kingdom
$2.96M +$735K +11,680 +30%
D.E. Shaw & Co
27
D.E. Shaw & Co
New York
$2.95M -$1.27M -20,194 -29%
AllianceBernstein
28
AllianceBernstein
Tennessee
$2.74M
California State Teachers Retirement System (CalSTRS)
29
California State Teachers Retirement System (CalSTRS)
California
$2.35M +$32.7K +520 +1%
QBFM
30
QS Batterymarch Financial Management
New York
$2.25M +$2.41M +38,305 New
CA
31
Commerzbank Aktiengesellschaft
Germany
$2.15M +$11.8K +188 +0.5%
Arrowstreet Capital
32
Arrowstreet Capital
Massachusetts
$1.63M +$1.75M +27,839 New
Nomura Holdings
33
Nomura Holdings
Japan
$1.46M +$148K +2,347 +10%
ProShare Advisors
34
ProShare Advisors
Maryland
$1.46M -$926K -14,700 -37%
Swiss National Bank
35
Swiss National Bank
Switzerland
$1.43M
Allianz Asset Management
36
Allianz Asset Management
Germany
$1.36M -$151K -2,397 -9%
GH
37
GAM Holding
Switzerland
$1.33M -$378K -5,996 -21%
USAA
38
United Services Automobile Association
Texas
$1.23M +$13.9K +220 +1%
RhumbLine Advisers
39
RhumbLine Advisers
Massachusetts
$1.2M -$94.5K -1,501 -7%
State Board of Administration of Florida Retirement System
40
State Board of Administration of Florida Retirement System
Florida
$1.17M
VFA
41
Virtus Fund Advisers
Connecticut
$1.1M +$1.18M +18,777 New
MLICM
42
Metropolitan Life Insurance Company (MetLife)
New York
$1.05M
American Century Companies
43
American Century Companies
Missouri
$1.05M +$248K +3,937 +28%
NFA
44
Nationwide Fund Advisors
Ohio
$991K +$1.07M +16,919 New
PA
45
Profund Advisors
Maryland
$859K -$217K -3,454 -19%
Manulife (Manufacturers Life Insurance)
46
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$821K -$158K -2,514 -15%
VOYA Investment Management
47
VOYA Investment Management
Georgia
$807K
BA
48
BlackRock Advisors
Delaware
$757K -$6.18M -98,196 -88%
BL
49
Bolton LP
Connecticut
$740K -$1.56M -24,770 -66%
DekaBank Deutsche Girozentrale
50
DekaBank Deutsche Girozentrale
Germany
$738K -$34.6K -550 -4%

ARNA Hedge Fund Activity: Q2 2014 in Review

129 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q2 2014, worth a combined $628M — down 2.6% from $645M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of ARNA and 19 opened new positions — a net loss of 2 holders — while 44 trimmed existing stakes and 33 added.

The largest buyer was Deerfield Management, adding an estimated $19.9M. The largest seller was BlackRock Advisors, cutting an estimated $6.18M.

  • 129 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q2 2014, down from 131 in Q1 2014.
  • Funds reported $628M of Arena Pharmaceuticals Inc stock for Q2 2014, down 2.6% quarter-over-quarter.
  • 19 funds opened new Arena Pharmaceuticals Inc positions in Q2 2014 and 21 closed out, a net change of -2 holders.
  • The largest Arena Pharmaceuticals Inc buyer in Q2 2014 was Deerfield Management, an estimated $19.9M added.
  • The largest Arena Pharmaceuticals Inc seller in Q2 2014 was BlackRock Advisors, an estimated $6.18M sold.

Based on aggregated 13F filings for Q2 2014.